Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
<p>Abstract</p> <p>Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are rare tumours that present many clinical features.</p> <p>They secrete peptides and neuroamines that cause distinct clinical syndromes, including carcinoid syndrome. However, many are clinica...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-03-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Online Access: | http://www.jeccr.com/content/29/1/19 |